Work

Supplementary Figure S2 from Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Year: 2023

Type: supplementary-materials

Abstract: Kaplan-Meier curves of PFS and OS in pooled group and arm A dichotomized by insulin receptor-B (IR-B) expression (high vs. low) using the 75th percentile of marker distribution as cutpoint.

DOI: 10.1158/1078-0432.22458800.v1

Authors: William J. Gradishar, Denise A. Yardley, Rachel Layman, Joseph A. Sparano, Ellen Chuang, Donald W. Northfelt, Gary N. Schwartz, Hagop Youssoufian, Shande Tang, Ruslan Novosiadly, Amelie Forest, Tuan S. Nguyen, Jan Cosaert, Dmitri Grebennik, Paul Haluska

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361917776

Cites:

Cited by:

Related to: 10